Misperceptions And Missteps: Schultz Speaks Out On CDRH Struggles
This article was originally published in The Gray Sheet
Executive Summary
Front-page criticism of FDA's device review process legitimately flags areas where the agency needs more work, though public misperceptions are also at play, says device center director Dan Schultz